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Purpose/Objective: To compare half (H-arc)- vs. quarter-arc 
(Q-arc) VMAT simultaneously integrated boost (SIB) approach 
to further reduce normal breast tissue dose burden using 
hypofractionated whole breast irradiation. 
Materials and Methods: Fifty-eight patients were included in 
this study using Pinnacle 9.6 (Philips, Best, NL). For the 
breast (PTV1) irradiation two tangential field-in-field beams 
were used, while treating the boost (PTV2) volume a single 
VMAT was applied. SIB was optimized using inverse SmartARC 
technique taking into account the dose contribution of the 
initial breast tangents. For all cases a tangent-to-tangent 
180° arc- (H-arc, single class solution) and a tumor bed 
location adapted 90-110° arcs (Q-arcs, two set of class 
solution) were created. Ipsilateral lung (IL), heart (H), 
contralateral breast (CB) were contoured as OARs. The 
following DVH parameters were used for comparison: V107 
(107% of breast prescription dose) for PTV1 and PTV1-2 (PTV1 
excluding the PTV2 volume), V95 (95% of boost prescription) 
for PTV1-2 and PTV2, and V107 for PTV2 (107% of the boost 
prescription). For the IL V18, for the H V15, Dmean, D2 and 
for the CB Dmean were compared using paired two tailed t-
test with a significance level of p<0.05. 
Results: There were no statistical differences between H-arc 
vs. Q-arcs VMAT SIB techniques in terms of PTV2 coverage 
(V95: 96.7 vs. 96.3 %, p=0.55) and conformity (V95boost for 
PTV1-PTV2: 2.2 vs. 1.9 %, p=0.28). Q-arcs VMAT SIB 
significantly reduced normal breast tissue dose burden 
(V107breast for PTV1-PTV2: 24.7 vs 21.7 %, p= 0.029). No 
statistical differences were observed between the dose-
volume parameters of the OARs (IL V18: 11.9 vs. 11.3 %, 
p=0.44, Dmean: 6.8 vs 6.7 Gy, p=0.3; CB: 0.5 vs. 0.9 Gy, 
p=0.85; H: Dmean: 2.2 vs. 2.1 Gy, p=0.85, V15: 2.8 vs. 2.3 
Gy, p=0.5, D2:15.6 vs. 13.7 Gy, p=0.58). Based on the early 
dosimetrical findings the last 23 patients were already 
treated with Q-arc SIB as opposed to our standard H-arc 
approach. 
Conclusions: Both VMAT techniques are excellent class 
solutions for breast SIB. However, location adapted Q-arc 
approach further improves plan quality compared to H-arc. 
Clinical evaluation is ongoing to assess whether dosimetric 
differences turns into reduced toxicity.  
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Purpose/Objective: Ischemic heart disease (IHD) is an 
important late effect of radiotherapy for breast cancer. In 
order to relate IHD to radiation dose to different cardiac 
structures, an accurate segmentation of these structures is 
necessary. It is expected that a multi-atlas-based auto-
segmentation of these structures will result in a more 
consistent segmentation of the cardiac structures and will 
save time. The purpose of this study is to validate multi-
atlas-based auto-segmentation of cardiac structures. 
Materials and Methods: In this retrospective study, 20 
patients were randomly selected after left breast irradiation 
at deep inspiration. The planning computed tomography (CT) 
scans of the first ten patients were used to build the multi-
atlas with dedicated software. The remainder 10 patients 
(validation group) were used to validate the multi-atlas-
based auto-segmentation by comparing the contours of the 
cardiac structures generated with the atlas-based 
segmentation with those generated by four observers and the 
reference segmentation (generated by an expert panel). The 
whole heart (WH), left and right ventricle (LV, RV), left and 
right atrium (LA, RA), aorta, coronary sinus and the four 
coronary arteries were delineated. The Dice Similarity 
Coefficient (DSC) was used to quantify the spatial overlap 
between the reference segmentation and the observer- and 
atlas-based segmentations, respectively. Furthermore, the 
observer- and atlas-based segmentations were blindly 
assessed for usefulness (score 1: no editing; 2 minor editing; 
3 major editing required. Scores 1 and 2 were considered 
clinically useful). 
Results: The multi-atlas-based segmentation algorithm was 
able to generate valid segmentations for all major cardiac 
structures (whole heart, 4 chambers and the aorta) within 
minutes, but not for the small structures (coronary sinus and 
the four coronary arteries), see figure 1. Manual 
segmentation of those structures took about 70 minutes per 
observer. The spatial overlap of the reference segmentation 
with both the segmentations of the different observers- 
(minimum DSC: 0.72) and the atlas-based segmentation 
(minimum DSC: 0.81) was very good. The majority (95%) of 
the atlas-based segmentations was clinically useful and 41% 




Figure 1 The reference segmentation together with the 
observer- and atlas-based segmentations of different heart 
structures (green: reference; yellow: atlas; blue, red, pink 
and orange: different observers). 
Conclusions: Atlas-based auto-segmentation is a valid and 
reliable alternative to manual segmentation for the major 
cardiac structures (whole heart, 4 chambers and the aorta). 
Moreover, atlas-based segmentation saves about 67 minutes 
time per patient compared to manual segmentation and 
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therefore, makes segmentation of different heart structures 
feasible in the clinic.  
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Purpose/Objective: There is an increasing tendency to 
consider axillary radiotherapy (AR) in preference to axillary 
node clearance (ANC) in early breast cancer following the 
recent results of the AMAROS trial which demonstrated 
equivalent local control but reduced arm lymphoedema after 
AR. Consequently AR is permissible within the POSNOC trial 
(evaluating the role of axillary treatment in women with 
early stage breast cancer and one or two sentinel node 
macrometastases).  
We set out to quantify axillary radiotherapy in terms of field 
placement and dose in UK radiotherapy centres participating 
in POSNOC.  
Materials and Methods: Data was collected from dummy run 
cases submitted as part of the POSNOC radiotherapy quality 
assurance programme and reviewed using radiotherapy plan 
visualisation software (VODCA). Anatomical points relative to 
the axillary nodal boundaries identified by RTOG (Radiation 
Therapy Oncology Group) within the Breast Cancer Atlas for 
Radiation Therapy Planning were defined to evaluate axillary 
field placement and dose to the axillary nodes at depth.  
• Field placement was assessed measuring the 50% isodose 
relative to the superior (cricoid cartilage), lateral (medial 
border of latissimus dorsi) and medial (trachea-midpoint 
cranial of the base of clavicle caudal of thyroid) extent of the 
axillary nodal boundaries.  
• Dose to the axillary nodal levels at depth was assessed by 
measuring a point dose at the posterior aspect of the 
midpoint of the cranial-caudal and lateral-medial extent of 
each nodal level boundary. 




Conclusions: The results suggest that treatment fields 
encompass the axillary nodal boundaries in the superior and 
lateral dimensions irrespective of planning approach. 
However, there is a potential compromise regarding the 
coverage of the medial nodal boundary, with some cases not 
encompassing the complete medial extent proximal to the 
trachea. Comparing volume with field based techniques 
suggests that coverage of the medial supraclavicular nodes is 
optimised when adopting a volumetric planning approach. 
The POSNOC radiotherapy guidelines recommend that ≥ 80% 
of the prescribed dose is achieved at mid-axilla and that the 
dose to the supraclavicular fossa nodes should be >90% of the 
prescribed dose. The point dose results suggest that each 
method of prescribing and/or beam arrangement for axillary 
nodal radiotherapy can achieve these dose levels, but in 
some cases level 1 nodes received less than 75% of the 
prescribed dose. The evaluation of anatomical reference 
points represents a simple method for evaluating axillary 
nodal coverage for centres not using a volumetric planning 
approach.  
POSNOC is funded by the National Institute for Health 
Research Health Technology Assessment (NIHR HTA) 
Programme-12/35/17. 
 
OC-0261   
Does chin fixation improve the setup accuracy of the 
patients receiving locoregional treatment for breast 
cancer? 
K. Goudschaal1, M. Kamphuis1, N. Bijker1, M. Frank1, A. Bel1, 
N. Van Wieringen1 
1Academic Medical Center, Radiotherapie, Amsterdam, The 
Netherlands  
 
Purpose/Objective: In our clinic breast cancer patients who 
receive locoregional treatment are positioned on a CQual 
breastboard (CIVCO, USA). This set-up leaves room for 
inaccuracies, especially in the area of the cervical vertebrae.  
The aim of this study is to determine whether fixation of the 
chin improves the stability of the supraclavicular lymph node 
area. 
Materials and Methods: 
 
 
Figure 1: chin fixation 
In April 2014 chin fixation was introduced in our department 
for patients that receive locoregional radiotherapy for breast 
cancer. This chin fixation is made using posicast 
thermoplastic mask material (Macromedics, the Netherlands) 
and is attached to the breastboard (figure 1). 
To evaluate the potential benefit of chin fixation, a 
comparison was made between two groups of patients 
positioned without/with chin fixation. The two groups 
contained the last 13 patients before introducing chin 
fixation and the first 13 patients with chin fixation. The 
group without chin fixation was given verbal instruction by 
RTTs to turn the chin 45 degrees to the contralateral side. 
For both patient groups IGRT is performed on daily basis or 
once a week, dependent of the IGRTprotocol, using Cone-
Beam CT (CBCT) imaging.  
Clinically the correction of the patient set-up was based on 
registration of the chest wall/sternum using a bone match 
algorithm in XVI. 80 CBCTs per group with an average of 6 
CBCTs per patient were used for this study.  
The number of CBCTs ranged between 3 and 11 per patient. 
The stability of the supraclavicular lymph node area is 
defined as the change of position with respect to the chest 
